Axiom Investors’s Medpace MEDP Stock Holding History

Axiom Investors’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-65,035	Closed	-$3.44M	–	134
2018 Q4	$3.44M	Buy	65,035 +3,965	+6%	+$218K	0.12%	88
2018 Q3	$3.66M	Buy	61,070 +6,620	+12%	+$362K	0.1%	98
2018 Q2	$2.34M	Buy	+54,450	New	+$2.2M	0.07%	121

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Axiom Investors's MEDP Position: Q1 2019 in Review

Axiom Investors sold out of Medpace (MEDP) in Q1 2019, closing a stake of 65,035 shares — an estimated $3.44M sold.

Axiom Investors first reported a position in MEDP in Q2 2018 and held it in 3 quarters. The position peaked at $3.66M in Q3 2018. 231 funds tracked by Wall St. Rank hold MEDP as of Q1 2019.

Axiom Investors reported no remaining Medpace position as of Q1 2019 after selling out during the quarter.
Axiom Investors sold 65,035 Medpace shares in Q1 2019, an estimated $3.44M.
Axiom Investors first reported a position in Medpace in Q2 2018 and held it in 3 quarters.
Axiom Investors's Medpace position peaked at $3.66M in Q3 2018.
231 funds tracked by Wall St. Rank held Medpace as of Q1 2019.

Based on Axiom Investors's 13F filing for Q1 2019, filed 13 May 2019.